Claritev Corp Annual Report Guide

For the fiscal year ended December 31, 2025, Claritev Corp, a leader in healthcare cost management, navigated a dynamic landscape, achieving consistent revenue growth and strategic expansion through key acquisitions. This annual report provides an in-depth look at the company's financial performance and strategic developments, including its complex debt structure and significant customer concentration risks.

Company Overview & Business Model

Claritev Corp uses technology to optimize healthcare costs and processes for its clients, which include health plans, self-insured employers, and government entities.

• Claims Intelligence Solutions: Uses advanced analytics and artificial intelligence (AI) to identify and prevent improper payments, detect fraud, waste, and abuse, and ensure claims accuracy, directly saving clients money.
• Network Solutions: Develops and manages high-performance provider networks. This includes focusing on value-based care, provider credentialing, and contract negotiation to improve quality and cost-effectiveness for clients.
• Payment and Revenue Integrity Solutions: Ensures accurate and secure financial transactions within the healthcare system, covering payment processing, revenue cycle management, and compliance services.

Claritev generates revenue through several key models:

• "Percentage of Savings" model: Claritev earns a commission on verifiable client cost savings. This model accounted for $1.1 billion (50% of total revenue) in 2025.
• "Per Employee Per Month" (PEPM) model: Clients pay a recurring fee per covered employee, offering a predictable revenue stream. This model generated $650 million (29.5% of total revenue) in 2025.
• Fixed-fee and subscription-based contracts: These contracts cover the remaining revenue, often for software licenses, data services, or consulting.

Competitive Position

Claritev operates in a highly competitive and evolving healthcare technology and services market. Its primary competitors include other healthcare cost management companies, large healthcare IT vendors, consulting firms, and in-house solutions developed by health plans and employers.

Claritev stands out with its proprietary AI-powered analytics platform, deep industry expertise, and flexible revenue models, including its "Percentage of Savings" approach. The company offers an integrated suite of solutions that address various aspects of healthcare cost containment. Demonstrating measurable return on investment (ROI) for clients, coupled with strategic acquisitions that expand its capabilities and market reach, provide key competitive advantages. Claritev continually invests in research and development to maintain technological leadership and adapt to market and regulatory changes.

Financial Performance Highlights (Fiscal Year 2025)

Claritev Corp achieved robust revenue growth for the third consecutive year, alongside improved profitability and cash flow.

Total Revenue Breakdown (in millions of dollars):

• Key Drivers: Growth primarily stemmed from increased adoption of Claims Intelligence Solutions, driven by new client wins and expanded services for existing clients, especially within the high-performing "Percentage of Savings" model.
• Profitability:
  • Gross Profit: Claritev achieved a gross profit of $1.54 billion in 2025, with a gross margin of 70% (up from 68% in 2024). This indicates efficient service delivery.
  • Operating Income: Operating income rose to $350 million in 2025, up from $300 million in 2024.
  • EBITDA: Adjusted EBITDA, a key measure of operational cash flow, increased to $450 million in 2025 from $380 million in 2024.
  • Net Income: Despite higher interest expenses, net income reached $180 million in 2025, or $1.80 per diluted share (based on approximately 100 million shares outstanding). This is an increase from $150 million ($1.50 per share) in 2024.
• Cash Flow:
  • Operating Cash Flow: The company generated $400 million in cash from operations in 2025, demonstrating strong underlying business performance.
  • Free Cash Flow: After $70 million in capital expenditures, free cash flow totaled $330 million, providing capital for debt reduction and strategic investments.

Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)

This section reviews Claritev Corp's financial condition and operating results for the fiscal year ended December 31, 2025, compared to prior periods. Readers should review this section alongside the audited consolidated financial statements and accompanying notes.

Results of Operations: Claritev achieved robust revenue growth of 8.4% in 2025, primarily from increased adoption of Claims Intelligence Solutions and new client wins, especially within the high-performing "Percentage of Savings" model. The acquisition of Benefits Science LLC in 2023 significantly contributed to 2025 revenue and enhanced predictive modeling capabilities. The gross profit margin improved to 70% in 2025, reflecting efficient service delivery and economies of scale. Operating income and Adjusted EBITDA also increased significantly, demonstrating effective cost management despite ongoing investments in technology and acquisitions. Net income grew, though higher interest expenses from debt incurred to fund strategic acquisitions partially offset this growth.

Financial Condition and Liquidity: Total assets grew to approximately $6.8 billion, reflecting investments in technology, intellectual property, and acquired businesses. Total liabilities, particularly debt, increased primarily to fund strategic acquisitions and support growth initiatives. The company's total debt increased to $4.05 billion in 2025, resulting in a highly leveraged capital structure, with a Debt-to-EBITDA ratio of approximately 9.0x. Managing this capital structure is a key focus for management. Claritev generated strong operating cash flow of $400 million and free cash flow of $330 million in 2025, which provides capital for debt reduction and strategic investments. A new $50 million revolving credit facility, with $20 million drawn, provides additional flexible liquidity. Management believes current cash flows from operations, available borrowings under the revolving credit facility, and access to capital markets will sufficiently meet its working capital needs, capital expenditures, debt service obligations, and strategic investments for the foreseeable future.

Critical Accounting Policies and Estimates: Preparing Claritev's consolidated financial statements under U.S. GAAP requires management to make estimates and judgments that affect reported assets, liabilities, revenues, and expenses. Key areas requiring significant estimates include revenue recognition (especially for the "Percentage of Savings" model), valuation of acquired intangible assets and goodwill, and assumptions for stock-based compensation and income taxes.

Off-Balance Sheet Arrangements: Claritev has no off-balance sheet arrangements that materially affect its financial condition, revenues, expenses, operating results, liquidity, capital expenditures, or capital resources.

Strategic Developments & Acquisitions

Claritev has actively pursued strategic acquisitions to expand its service offerings and market reach.

• Acquisition of Benefits Science LLC (BST) (May 2023): This acquisition significantly expanded Claritev's data analytics capabilities and client base in the self-insured employer market. BST contributed an estimated $120 million to Claritev's 2025 revenue and enhanced its predictive modeling for cost containment.
• Acquisition of OPCG LLC (OPCG) (November 2025): The acquisition of OPCG, a specialist in provider credentialing and network optimization, strategically strengthens Claritev's Network Solutions segment. This move is expected to broaden Claritev's service offerings, improve client network efficiency, and contribute to revenue growth starting in fiscal year 2026. The acquisition was primarily debt-financed.
• Strategic Rationale: These acquisitions align with Claritev's strategy to enhance its integrated platform, expand market reach, and deepen its value proposition by offering clients more comprehensive, data-driven healthcare cost management solutions.

Financial Position & Debt Profile

Claritev's balance sheet reflects significant growth, alongside a highly leveraged capital structure.

• Balance Sheet Snapshot (as of December 31, 2025):
  • Total Assets: Approximately $6.8 billion
  • Total Liabilities: Approximately $5.7 billion (including $4.05 billion in total debt)
  • Shareholders' Equity: Approximately $1.1 billion
• Total Debt: Claritev's total reported debt increased from $3.78 billion in 2024 to $4.05 billion in 2025, primarily to fund acquisitions and support growth initiatives.
• Debt Structure:
  • New Debt in 2025: Claritev issued $150 million in "Third-Out First Lien A Notes" and $100 million in "Third-Out First Lien B Notes," both with an average interest rate of 7.5% and maturing in 2030.
  • 2025 Revolving Credit Facility: Claritev established a new $50 million facility, drawing $20 million by year-end 2025. This provides flexible liquidity at a variable interest rate (currently 6.0%).
  • Senior Convertible PIK Notes: These notes increased from $280 million in 2024 to $300 million in 2025. PIK (Payment-In-Kind) notes allow Claritev to pay interest by issuing additional notes instead of cash. While this conserves cash flow, it increases the principal debt balance over time. These notes are convertible into equity under certain conditions, potentially leading to future shareholder dilution.
• Debt Metrics: The company's Debt-to-EBITDA ratio reached approximately 9.0x in 2025, reflecting a highly leveraged capital structure. Key debt covenants require maintaining a minimum liquidity threshold and specific leverage ratios.

Key Risk Factors

Investors should consider several key risks impacting Claritev Corp:

• Customer Concentration: Claritev faces significant customer concentration risk. Customer One accounted for 15% of total net sales revenue in 2025 (down from 18% in 2024), and Customer Two accounted for 12% (up from 10% in 2024). Losing or significantly reducing business from either of these key clients could materially impact financial results.
• Regulatory Environment: The highly regulated healthcare industry presents ongoing risks from changes in laws, policies, and compliance requirements (e.g., HIPAA, ACA). These changes could impact Claritev's operations and service offerings.
• Competition: Claritev operates in a competitive market with various established players and new entrants. Failure to innovate or maintain a competitive edge could affect market share and profitability.
• Technology & Data Security: Reliance on complex technology platforms and handling sensitive patient data exposes Claritev to risks of system failures, cyberattacks, and data breaches. These could lead to financial losses, reputational damage, and legal liabilities.
• Acquisition Integration: Successfully integrating acquired companies like BST and OPCG is crucial. Failure to effectively integrate operations, technologies, and personnel could hinder expected synergies and financial benefits.
• High Leverage & Interest Rate Risk: The substantial debt load and exposure to variable interest rates (on the revolving credit facility) make Claritev sensitive to interest rate fluctuations. This could increase debt servicing costs and impact profitability.

Future Outlook & Strategic Priorities

Claritev Corp is positioned for continued growth, driven by the increasing demand for healthcare cost containment solutions and the strategic expansion of its service portfolio through recent acquisitions.

• Key Strategic Priorities: Management's focus for the upcoming year includes successfully integrating acquired entities, expanding AI and data analytics capabilities across all solution segments, and deepening client relationships to drive organic growth.
• Market Trends: The company anticipates continued tailwinds from rising healthcare costs, the shift towards value-based care, and the need for greater transparency and efficiency in healthcare spending.
• Management aims to improve operational efficiency and leverage its expanded platform to enhance profitability and gradually deleverage its balance sheet over the long term.